4 unread notifications
Omri Drory leads NFX Bio as a general partner, investing at the intersection of biology and technology. He founded and led Genome Compiler through its acquisition by Twist Bioscience, then led corporate development at Twist before founding tech.bio.
Omri Drory leads NFX Bio as a general partner, investing at the intersection of biology and technology. He founded and led Genome Compiler through its acquisition by Twist Bioscience, then led corporate development at Twist before founding tech.bio.
Career
Omri Drory studied at Tel Aviv University (PhD, Biochemistry and BS, Biochemistry and Molecular Biology).
General Partner at NFX from 2020 to PresentTFounding Partner at tech.bio from 2018 to Present
TBHead of Corporate Development at Twist Bioscience from 2016 to 2018
GCFounder and CEO at Genome Compiler from 2011 to 2016
SUPostdoctoral Associate at Stanford University School of Medicine from 2007 to 2011
